secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENvue Medical, Inc. (FEED)
CIK:        0001326706
Form:       8-K
Filed at:   2026-10-14T21:28:05+00:00
Accession:  0001493152-26-047063
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 5.03, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

ENvue Medical raises up to $1M secured from Alpha Capital; Series X conversion cut to $0.50
--------------------------------------------------------------------------------

- Entered Secured Promissory Note with Alpha Capital Anstalt for up to $1,000,000; $250,000 initial tranche funded Oct 8, 2026.
- Note accrues 10% interest, rising to 18% on default; matures Dec 31, 2026 and lender may extend in 3-month increments to Dec 31, 2028.
- Secured by substantially all assets: accounts, inventory, manufacturer deposits, patents, trademarks, copyrights and subsidiary equity.
- Series X Preferred conversion price lowered to $0.50/share; holders of at least 70% amended the dilutive-issuance price adjustment terms.
- Certificate of Amendment filed with Delaware Secretary of State Oct 12, 2026; CEO Doron Besser signed the report.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326706/000149315226047063/0001493152-26-047063-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326706/000149315226047063/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-047063

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer